We're aware of a cyber security incident affecting the electronic prescriptions provider MediSecure. The eRX Script Exchange (eRX) and the National Prescription Delivery Service (NPDS) continue to operate as usual and have not been impacted. Find out more and read our statement here.

RACGP submission to Review of Phase 4 of the National Bowel Cancer Screening Program consultation

Last updated 22 July 2022


Date: 1 July 2022

The Department of Health sought feedback from key stakeholders in relation to their public consultation paper for the review of the Phase 4 of the National Bowel Screening Program (the Program).
The RACGP response highlights several risks that require consideration in the Program to improve patient participation including:

  • the impact of long public hospital waiting lists for colonoscopy
  • the need to improve standardised colonoscopy care in Australia.
It highlights:
  • the importance of evidence-based guidelines to inform health professional care and follow-up
  • the need for a system that identifies and links colonoscopy results from specialists into a registry that can be accessed from GP electronic medical record systems, like the National Cancer Screening Register.